Immunitybio, Inc.
Clinical trials sponsored by Immunitybio, Inc., explained in plain language.
-
New immune drug tested in tough pancreatic cancer cases
Disease control CompletedThis study tested a new drug called HCW9218 in people with advanced pancreatic cancer that had worsened despite standard treatment. The main goals were to find a safe dose and see if the drug could help control the cancer. It was a small, early-stage trial involving 21 participan…
Phase: PHASE1, PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test drug to boost natural killer cells in healthy volunteers
Knowledge-focused CompletedThis early-phase study tested how a drug called N-803 affects natural killer immune cells collected from healthy people. Ten healthy volunteers donated blood cells twice—once before and once after receiving an N-803 injection. Researchers measured safety and compared how the drug…
Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC